Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Video

» Topical Discussion

Understanding Early and Late Mortality in Low Risk Randomized Trials

February 7, 2024

Video

TVT 2019: Highlights From the PARTNER 3 Low-Risk Trial

June 27, 2019

Video

TVT 2019: Highlights From the Evolut Low-Risk Trial

June 13, 2019

Video

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

June 14, 2019

Video

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

June 14, 2019

Video

» Topical Discussion

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR

February 6, 2024

Video

» Topical Discussion

TAVR - Moving to Low Risk: New Devices / Strategies to Reduce Complications

May 11, 2018

Video

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

June 26, 2018

Video

» Topical Discussion

Post-Procedure Care of TAVR Patients

March 25, 2019

Video

» Topical Discussion

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

February 6, 2024

Video

» Interview

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

November 4, 2021

Video

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

September 29, 2019

Video

» On Record

On Record: TAVR’s March to Low-Risk Patients

May 11, 2018

Video

» On Record

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

May 11, 2018

Video

» Topical Discussion

Lifetime Management Considerations in Low Risk Patients

February 7, 2024

Video

» Topical Discussion

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

February 7, 2024

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Raj Makkar About the PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

September 26, 2019

Video

Debate- All AS Patients (incl. Low-Risk) Should Be Treated With TAVI

January 9, 2020

Video

» Interview

Beyond the Data: Low-risk Patients in NOTION-2

May 16, 2024

Video

» Interview

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

March 18, 2019

Advertisement

Understanding Early and Late Mortality in Low Risk Randomized Trials

TVT 2019: Highlights From the PARTNER 3 Low-Risk Trial

TVT 2019: Highlights From the Evolut Low-Risk Trial

TVT 2019: Hemodynamic Outcomes and Predictors of Prosthesis-Patient Mismatch After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients: Results from the Evolut Low-Risk Trial

TVT 2019: Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

The Clinical Impact of Bioprosthetic Valve Performance After Surgery and TAVR

TAVR - Moving to Low Risk: New Devices / Strategies to Reduce Complications

SHDS 2018: Counterpoint: Most Bicuspid Aortic Valves (Especially In Younger Low-Risk Patients) Will Remain in the Surgical Domain!

Post-Procedure Care of TAVR Patients

Patients Enrolled in the Evolut™ Low Risk Trial - the Critical Role of the Heart Team

PARTNER 3: Two-Year Economic Outcomes From a Randomized Trial of TAVR vs. SAVR in Patients at Low Surgical Risk

PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk

On Record: TAVR’s March to Low-Risk Patients

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

Lifetime Management Considerations in Low Risk Patients

High-Level Results of the Evolut™ Low Risk Randomized Clinical Trial

Dr. C. Michael Gibson Talks With Dr. Raj Makkar About the PARTNER 3 Low-Risk Computed Tomography Substudy: Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic Valves

Debate- All AS Patients (incl. Low-Risk) Should Be Treated With TAVI

Beyond the Data: Low-risk Patients in NOTION-2

ACC 2019: Self-Expanding Transcatheter or Surgical Aortic Valve Replacement in Patients at Low Risk of Surgical Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content